Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria. | Aplastic Anemia & MDS International Foundation Return to top.

Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.

Journal Title: 
Am J Hematol
Primary Author: 
Emadi A
Author(s): 
Emadi A, Brodsky RA.
Original Publication Date: 
Thursday, October 1, 2009

No abstract available.

Bone Marrow Disease(s): 
  • paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.